Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.

Bayer said the Food and Drug Administration extended the review period for its new drug application of elinzanetant, a treatment for moderate to severe vasomotor symptoms, also known as hot flashes, ...

The combinations are also approved for relapsed or refractory multiple myeloma in Japan, the UK and other markets including Switzerland and Canada.

GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...

London: GSK plc has announced the extension of the US Food and Drug Administration (FDA) review period for the Biologics ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

An 84-game season is coming to the NHL as part of an extension of the collective bargaining agreement that has been tentatively agreed to by the league and the Players’ Association. They ...

As the calendar moves closer to free agency, Chicago Cubs right fielder Kyle Tucker must decide in the offseason what he will prioritize when he signs a long-term deal.

President Trump on Thursday signed an executive order giving TikTok a 90-day extension to work out a deal with the U.S. government that addresses security concerns over the app's ties to China.

President Trump has signed an order giving TikTok another extension to address the U.S. government's security concerns involving the video app's ties to China.